Challenging cases and diagnostic dilemmas: case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease.
Bomanji
J B
JB
Institute of Nuclear Medicine and Meyerstein Institute of Oncology, Middlesex Hospital, London, United Kingdom.
Syed
R
R
Brock
C
C
Jankowska
P
P
Dogan
A
A
Costa
D C
DC
Ell
P J
PJ
Lee
S M
SM
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D019788:Fluorodeoxyglucose F18; D006099:Granuloma / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008477:Mediastinal Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy; D014055:Tomography, Emission-Computed
D019788:Fluorodeoxyglucose F18